By InvitationNot Applicable

ADHAirE : a Randomized Controlled Trial to Improve the Implementation of Tobacco-free School Policies

Belgium20 participantsStarted 2024-04-25

Plain-language summary

The goal of this cluster randomized controlled trial is to learn if the set up of an advocacy coalition in secondary schools can improve the implementation of tobacco-free school policies (TFSP) to prevent adolescent smoking. The main questions it aims to answer are: 1. To what extent is an advocacy coalition related to smoking prevention implementable in school's routine ? 2. Is an advocacy coalition an effective way to prevent smoking among adolescents and shift smoking norms in school? Schools in the intervention arm will be compared to schools in the control arm, to test the effectiness of the advocacy coalition to improve the implementation of TFSP. Schools in the intervention arm will put in place an advocacy coalition, that is * Set up a task force composed of school stakeholders (students, teachers, educators, principle,...) * Share their good practices regarding implementation with the other schools of the intervention arm * Be supported to reffer nicotine-dependant students and staff members to smoking cessation programs Continuous evaluation is planned to assess the effectiveness of this intervention.

Who can participate

Age range

13 Years – 19 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

These criteria concern adolescents who will take part in the surveys. Inclusion Criteria: * student at a secondary school participating in the study * student of the 3rd and 4th grade Exclusion Criteria: * student at a secondary school not participating in the study * student of another grade than 3rd and 4th grade

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Smoking prevalence

Timeframe: 2 years

Trial details

NCT IDNCT06655038

SponsorUniversité Catholique de Louvain

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Smoking trials